Details werden geladen...
MiNK Therapeutics to Report First Quarter 2026 Financial Results and Highlight Platform Progress Across iNKT Cell Therapy Programs | The Manila Times
NEW YORK, May 08, 2026 (GLOBE NEWSWIRE) -- MiNK Therapeutics, Inc. (NASDAQ: INKT), a clinical-stage biopharmaceutical company pioneering allogeneic invariant natural killer T (iNKT) cell therapies to treat cancer and immune disorders, today announced that it will report financial results for the first quarter ended March 31, 2026, before the market opens on Friday, May 15, 2026.
Ähnliche Seiten
MiNK Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results and Highlight Platform Expansion Across iNKT Cell Therapy Programs | The Manila Times
https://www.manilatimes.net/2026/03/17/tmt-newswire/globenewswire/mink-therapeutics-to-report-fourth-quarter-and-full-year-2025-financial-results-and-highlight-platform-expansion-across-inkt-cell-therapy-programs/2301660Cellectis to Report First Quarter Financial Results on May 11, 2026 | The Manila Times
https://www.manilatimes.net/2026/05/05/tmt-newswire/globenewswire/cellectis-to-report-first-quarter-financial-results-on-may-11-2026/2335433Motorsport Games to Report First Quarter 2026 Financial Results | The Manila Times
https://www.manilatimes.net/2026/05/09/tmt-newswire/globenewswire/motorsport-games-to-report-first-quarter-2026-financial-results/2339796InflaRx to Report First Quarter 2026 Results on May 7, 2026 | The Manila Times
https://www.manilatimes.net/2026/05/01/tmt-newswire/globenewswire/inflarx-to-report-first-quarter-2026-results-on-may-7-2026/2333709CRISPR Therapeutics Provides Business Update and Reports First Quarter 2026 Financial Results | The Manila Times
https://www.manilatimes.net/2026/05/05/tmt-newswire/globenewswire/crispr-therapeutics-provides-business-update-and-reports-first-quarter-2026-financial-results/2335435